N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide

C60H66N10O2+2 — CID 145241032

IUPACN-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide
SMILESCC#C[n+]1c2cc(N)c(C)cc2nc2cc(C)c(NCCCCCCNC(=O)c3ccc(-c4ccc(C(=O)NCCCCCCNc5cc6c(cc5C)nc5cc(C)c(N)cc5[n+]6C#CC)cc4)cc3)cc21
InChIInChI=1S/C60H64N10O2/c1-7-29-69-55-35-47(61)39(3)31-51(55)67-53-33-41(5)49(37-57(53)69)63-25-13-9-11-15-27-65-59(71)45-21-17-43(18-22-45)44-19-23-46(24-20-44)60(72)66-28-16-12-10-14-26-64-50-38-58-54(34-42(50)6)68-52-32-40(4)48(62)36-56(52)70(58)30-8-2/h17-24,31-38H,9-16,25-28H2,1-6H3,(H6,61,62,63,64,65,66,71,72)/p+2
InChIKeyZNFMDOWFFFDPJM-UHFFFAOYSA-P
MW959.26 g/mol
LogP10.19
Rot. Bonds19

About N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide

N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide (PubChem CID 145241032) has the molecular formula C60H66N10O2+2 and a molecular weight of 959.26 g/mol. Its IUPAC name is N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide.

Molecular Properties

Compound NameN-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide
PubChem CID145241032
Molecular FormulaC60H66N10O2+2
Molecular Weight959.26 g/mol
Exact Mass958.54
IUPAC NameN-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide
SMILESCC#C[n+]1c2cc(N)c(C)cc2nc2cc(C)c(NCCCCCCNC(=O)c3ccc(-c4ccc(C(=O)NCCCCCCNc5cc6c(cc5C)nc5cc(C)c(N)cc5[n+]6C#CC)cc4)cc3)cc21
InChIInChI=1S/C60H64N10O2/c1-7-29-69-55-35-47(61)39(3)31-51(55)67-53-33-41(5)49(37-57(53)69)63-25-13-9-11-15-27-65-59(71)45-21-17-43(18-22-45)44-19-23-46(24-20-44)60(72)66-28-16-12-10-14-26-64-50-38-58-54(34-42(50)6)68-52-32-40(4)48(62)36-56(52)70(58)30-8-2/h17-24,31-38H,9-16,25-28H2,1-6H3,(H6,61,62,63,64,65,66,71,72)/p+2
InChIKeyZNFMDOWFFFDPJM-UHFFFAOYSA-P
XLogP10.19
TPSA167.84 Ų
H-Bond Donors6
H-Bond Acceptors8
Rotatable Bonds19
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500959.26
LogP ≤ 510.19
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide?
The IUPAC name of N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide (CID 145241032) is N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide.
What is the SMILES notation for N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide?
The canonical SMILES for N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide is CC#C[n+]1c2cc(N)c(C)cc2nc2cc(C)c(NCCCCCCNC(=O)c3ccc(-c4ccc(C(=O)NCCCCCCNc5cc6c(cc5C)nc5cc(C)c(N)cc5[n+]6C#CC)cc4)cc3)cc21.
What is the InChIKey of N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide?
The InChIKey is ZNFMDOWFFFDPJM-UHFFFAOYSA-P. The full InChI is InChI=1S/C60H64N10O2/c1-7-29-69-55-35-47(61)39(3)31-51(55)67-53-33-41(5)49(37-57(53)69)63-25-13-9-11-15-27-65-59(71)45-21-17-43(18-22-45)44-19-23-46(24-20-44)60(72)66-28-16-12-10-14-26-64-50-38-58-54(34-42(50)6)68-52-32-40(4)48(62)36-56(52)70(58)30-8-2/h17-24,31-38H,9-16,25-28H2,1-6H3,(H6,61,62,63,64,65,66,71,72)/p+2.
What are the key properties of N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide?
N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide has a molecular weight of 959.26 g/mol, XLogP of 10.19, 19 rotatable bonds, 6 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexyl]-4-[4-[6-[(8-amino-3,7-dimethyl-10-prop-1-ynylphenazin-10-ium-2-yl)amino]hexylcarbamoyl]phenyl]benzamide is sourced from PubChem (CID 145241032), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).